Multiple sclerosis (MS) is characterized by an immune system attack targeting myelin, which is produced by oligodendrocytes (OLs). We performed single-cell transcriptomic analysis of OL lineage cells from the spinal cord of mice induced with experimental autoimmune encephalomyelitis (EAE), which mimics several aspects of MS. We found unique OLs and OL precursor cells (OPCs) in EAE and uncovered several genes specifically alternatively spliced in these cells. Surprisingly, EAE-specific OL lineage populations expressed genes involved in antigen processing and presentation via major histocompatibility complex class I and II (MHC-I and -II), and in immunoprotection, suggesting alternative functions of these cells in a disease context. Importantly, we found that disease-specific oligodendroglia are also present in human MS brains and that a substantial number of genes known to be susceptibility genes for MS, so far mainly associated with immune cells, are expressed in the OL lineage cells. Finally, we demonstrate that OPCs can phagocytose and that MHC-II-expressing OPCs can activate memory and effector CD4-positive T cells. Our results suggest that OLs and OPCs are not passive targets but instead active immunomodulators in MS. The disease-specific OL lineage cells, for which we identify several biomarkers, may represent novel direct targets for immunomodulatory therapeutic approaches in MS.
EAE mice spinal cord cells segregated from CFA control mice, with a subset of clusters uniquely found in EAE ( Fig. 1c , Supplementary  Fig. 1b,e ). Clustering analysis (GeneFocus pipeline, see Methods and Supplementary Fig. 2 ) revealed fourteen OL lineage clusters, including four clusters of OPCs, one differentiation-committed oligodendrocyte precursor (COP), one newly formed OL (NFOL) and eight mature OL (MOLs; Fig. 1d and Supplementary Fig. 1c ). We also identified vascular and leptomeningeal cells (VLMCs) 3, 4 , consistent with the labeling of this population with Pdgfra, and microglia-like cells (which, while they could also include macrophages, we refer to as microglia; Fig. 1c and Supplementary Fig. 1b ), which could reflect transient Pdgfra expression in these cells, or phagocytosis of myelin-associated GFP.
EAE-enriched OPC populations comprised OPCcyc (cycling), OPC2 and OPC3, distinct from the OPC1 population found in healthy mice ( Supplementary Fig. 1e ) that shares a transcriptional profile similar to that previously identified postnatal and adult mouse OPCs 3,4 ( Fig. 1e and Supplementary Fig. 3d-f ). Dimensionality reduction using non-negative matrix factorization (NNMF) yielded a rank of 8 components (see Methods). Removal of components 7 and 8 that correlated to S and G2 phase cell-cycle genes revealed that OPCcyc can be further deconvoluted, suggesting that the OPCcyc population describes a mixture of cell-state transitions from OPC1, OPC2 and OPC3 ( Supplementary Fig. 3 ). Comparison of OPC populations showed specific expression of genes such as Rph3a, Adora2b in OPC1, Phyhd1, Sult1a1 in OPC2 and Slc14a1 in OPC3 ( Fig. 1e and Supplementary Table 1 ). OPC2 and OPC3 clusters displayed unique expression of Fcgr2b, Mylk, Lgals1 (Fig. 1e ,g, Supplementary Fig. 4a and Supplementary Table 1 ), when compared with OPC1, and increased levels of Myrf (Fig. 1e) , a transcription factor necessary for myelination 8 , and decreased levels of Hes1 and Hes5 ( Supplementary Fig. 4a ), which keep OPCs in a progenitor state 9 . The COPs and NFOLs expressing Col20a1 (Fig. 1g ) and Syt4 ( Supplementary Fig. 4a ) were mostly from EAE mice. Thus, OPCs undergo proliferation and differentiation in EAE 10, 11 , but also transition to previously unidentified transcriptional states.
MOLs presented several markers identified in Marques et al. 4 , and could be subcategorized accordingly (Fig. 1d,f and Supplementary  Fig. 1c ). EAE-associated MOL lineage populations expressed unique genes, absent or very low expressed in healthy controls. ; only animals that reached score 3 and one that reached score 2.5 were used in this study). c, t-Distributed stochastic neighbor embedding (t-SNE) plots of all cells sequenced showing the segregation of cells derived from CFA controls and EAE (n = 4 biologically independent mouse spinal cord samples per condition; total number of cells is 794 for controls and 971 for EAE). d, t-SNE plots of all cells sequenced representing different cell populations within OL lineage cells. MOL identities were defined according to marker genes identified in ref. 4 (n = 4 biologically independent mouse spinal cord samples per condition; total number of cells is 745 for controls and 707 for EAE). e,f, Violin plots depicting the expression of specific markers for OPCs (e) and for MOL clusters (f) (n = 4 biologically independent mouse spinal cord samples per condition; total number of cells is 116 for OPC controls and 132 for OPC EAE and 626 for MOL controls and 575 for MOL-EAE). Violin plots are centered around the median with interquartile ranges and shape represents cell distribution. g, t-SNE plots of disease-specific markers for OL lineage cells (n = 4 biologically independent mouse spinal cord samples per condition; total number of cells is 745 for controls and 707 for EAE). h, Schematic representation of the exon 6 inclusion in the Pdgfa gene in response to EAE. i, Violin plot representing the proportion of spliced isoform (PSI) in controls (MOL2 Ct-a depicted in green) and EAE (MOL1/2-EAE depicted in purple) of the alternative spliced exons in Pdgfa and Mbp genes. PSI = 0 means totally excluded and PSI = 1 totally included (n = 4 biologically independent mouse spinal cord samples per condition; total number of cells is 56 for MOL2 Ct-a and 49 for MOL1/2-EAE; Pdgfa ex6: P = 0.0003176 and Mbp ex2: P = 5.323 × 10 −11 by two-sided Wilcoxon rank-sum test with continuity correction; violin plots are centered around the median with interquartile ranges and shape represents cell distribution. VLMCs, vascular and leptomeningeal cells; MiGl, microglia-like cells.
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Sult1a1 and Zfand4 in MOL5/6-EAE-a; and S100a10, RNAse4 and Tnfrsf1a, a MS susceptibility gene 12 , in MOL5/6-EAE-b ( Fig. 1f ,g, Supplementary Fig. 4a and Supplementary Table 1 ). We found disease-specific markers in OL lineage cells such as Igtp, Nlrc5 and Serpina3n ( Fig. 2b and Supplementary Fig. 4a ). Il12rb1 was present in all MOL populations found in EAE mice ( Fig. 1g ). All OL lineage clusters comprised cells from both transgenic mouse lines, with the exception of MOL5/6-EAE-a, from Pdgfra-H2B-GFP mice, which might thus be composed of 'young' OLs ( Supplementary Fig. 1e ).
To identify gene-transcription trends, we decomposed the dataset into components using NNMF ( Supplementary Fig. 4b ) and found 19 robust gene modules, including two that were uniquely associated with EAE: module 1, present in a subset of EAE cells comprising genes related to interferon response pathways and MHC-I and -II genes, and module 13 restricted to the MOL5/6-EAE-a population, which contained genes such as Plin4, Hif3a and Fam107a ( Supplementary Fig. 4b ). Similar results were obtained when performing Gene Ontology (GO)/Reactome analysis (Supplementary  Figs. 4c and 5a, and Supplementary Table 3 ). We also uncovered 360 genes that were alternatively spliced in EAE OL lineage cells, with either exon exclusion or inclusion (Supplementary Table 2 ). GO/Reactome analysis showed that genes with alternatively spliced exons in EAE OPCs were related to regulation of transcriptional elongation from RNA polymerase II (exon exclusion), membrane trafficking (exon inclusion), and RNA-splicing components (exon exclusion; Supplementary Fig. 5b and Supplementary Table 3 ). We also found evidence of alternative splicing in EAE in several genes involved in myelination and MS, including the myelin genes 
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Mbp (as previously reported 13 ), Mobp, Pdgfa and the Ifih1 gene, in which MS-associated polymorphisms have been found 14 (Fig. 1h ,i Supplementary Fig. 5c and Supplementary Table 2 ). We performed RNAscope in situ hybridization (ISH) and immunohistochemistry (IHC) in EAE spinal cords against several markers of the identified clusters, such as Klk8, which specifically marks MOL1/2-EAE ( Fig. 1g) and Hopx, which marks MOL2 4 . While control spinal cords exhibited sparse Klk8 expression we observed a strong induction of Klk8 in a subset of Hopx + /Sox10 + MOL2 in EAE mice ( Fig. 2a ). We also confirmed the presence of PLIN4 protein (enriched in MOL5/6-EAE-a) by performing IHC on spinal cords and found elevated GFP/PLIN4 double-positive cells (from the Pdgfra-H2B-GFP mouse) and Sox10/PLIN4 ( Supplementary  Fig. 6a ) in EAE mice. Thus, Klk8 and Plin4 are new markers of subpopulations of EAE-responsive MOLs.
All oligodendroglia in EAE displayed elevated Serpina3n expression ( Fig. 2b) , encoding a serine protease inhibitor that has been shown to reduce EAE severity and induce neuroprotection 15 . We confirmed the increase in Serpina3n in EAE by RNAscope ISH, especially notable within Sox10 + cells (Fig. 2c ). The expression of this molecule reached such high levels in EAE, that we could no longer detect single dots. Interestingly, we found expression of additional genes of the Serpina3 family, including Serpina3h, Serpina3c, Serpina3i, Serpina3f and Serpina3g specific to MOL1/2-EAE ( Fig. 2b) , which could suggest that this population might be protected against direct damage by T or NK cells. This population also expresses the gene Serping1 (Fig. 2b ) encoding for an inhibitor of complement activation, another possible mechanism of immunoprotection.
MHC-I genes, such as H2-K1, H2-D1, H2-T23, B2m, and genes necessary for antigen processing and binding to MHC-I molecules, such as Psmb9, Tap1 and Tap2, were significantly increased on EAE induction in OL lineage cells ( Fig. 2d and Supplementary Table 1 ). Thus, EAE OLs might be direct targets of cytotoxic T cells, which is consistent with their expression of myelin epitopes. Surprisingly, however, we found that OPCs also exhibited a robust increase in the expression of these molecules ( Fig. 2d ), suggesting that OPCs might also be targeted during the disease, despite not expressing myelin proteins. To validate the expression of MHC-I molecules in oligodendroglia cells, we performed RNAscope ISH and observed an upregulation of B2m molecules in Sox10 + cells in EAE spinal cords as well as the presence of Psmb9 molecules in Sox10 + cells in EAE that were absent in Sox10 + cells in control spinal cords ( Fig. 2e) .
MHC-II genes are thought to be restricted to microglia/macrophages in MS, and not present in OLs in active lesions 16 . Strikingly, we found the expression of all key genes required for a MHC-II mediated response, including H2-Aa, H2-Ab1, H2-Eb1, Cd74 and Ctss, in specific subsets of OPCs and OLs (Fig. 3a) . To confirm the presence of these RNA transcripts in OL lineage cells, we performed RNAscope ISH in the EAE and control spinal cords using probes targeting Cd74 and H2-Eb1 (for MHC-II), in combination with Aif1 (for microglia), Sox10 (for OL lineage cells), Klk6 (for MOL2) and Ptprz1 (for OPC) ( Fig. 3b-d , Supplementary Fig. 6b , and Supplementary Videos 1-6). While we observed microglia processes enwrapping OLs (Supplementary Video 7), a small proportion of OLs/OPCs could be confidently assigned with doublepositive Cd74/Sox10 and few or no molecules for Aif1 ( Fig. 3d and Supplementary Videos 1-7). We also combined RNAscope ISH with IHC and found triple-positive OPCs for GFP (from EAE Pdgfra-H2B-GFP spinal cord), Ptprz1 and Cd74 ( Fig. 3c and Supplementary Video 2). We also performed IHC for MHC-II and the OL markers OLIG2 and SOX10, and identified double-positive cells for OLIG2/MHC-II and SOX10/MHC-II oligodendroglia in the spinal cord of EAE mice ( Fig. 3e and Supplementary Fig. 6c ). We estimated that in the lesion areas of the white matter SOX10/ MHC-II double oligodendroglia constitute about 3.4% (± 1.76 s.d.)
of the SOX10 + cells. We performed IBA-1 staining to distinguish between SOX10/MHC-II oligodendroglia and MHC-II-expressing macrophages/microglia and we could distinguish the two cell types. Nevertheless, IBA-1 could still be observed in SOX10/MHC-II oligodendroglia although with a lower expression, which could be due to induction of some Aif1 molecules (corresponds to IBA-1 protein) in oligodendroglia in EAE, by, for instance, interferongamma (IFN-γ ) 17 . Control CFA-treated spinal cord OPCs/OLs did not express MHC-II molecules at either the RNA (RNAscope ISH) or protein level (IHC; Fig. 3b and data not shown).
We found several interferon-responsive genes in MHC-II expressing OL/OPC populations, such as Ifih1, Trim34, Irf7, Irgm1, Irgm2, Igtp and Zbp1 ( Supplementary Fig. 7a ). It has been shown that IFN-γ can trigger endoplasmic reticulum stress in OLs 18 . Indeed, we found many genes involved in protein processing in endoplasmic reticulum differentially expressed in EAE ( Supplementary Fig. 7b ). Transcription factors such as Nlrc5, a transactivator of the MHC-I 19 , were expressed on disease in all OL lineage cells, and Ciita, induced by the IFN-γ pathway and activator of MHC-II genes, was expressed in a subset of these cells ( Supplementary Fig. 4a ). Thus, OL/OPC populations in the spinal cord appear to have the capacity to activate MHC genes on EAE induction.
To determine if these populations also occur in human MS, we performed IHC for MHC-II and the OL markers OLIG2 and OLIG1 in postmortem brain tissue from two MS patients. As in mouse model EAE, we observed cells in which immune cellderived MHC-II processes appear to touch/enwrap OLIG2 + nuclei ( Supplementary Fig. 6d arrowheads and Supplementary Video 8) but also OLIG2 and OLIG1 cells positive for MHC-II without any immune cell in their neighborhood ( Fig. 3f and Supplementary  Fig. 6d arrows, and Supplementary Video 9), indicating that human OLs can indeed express adaptive immunity proteins in the context of MS.
Several MS susceptibility variants including MHC and autosomal non-MHC locus and the associated putative susceptibility genes have recently been described 1 . Comparison of these loci/genes with RNA-seq from bulk brain led to the inference that peripheral immune system cells and brain-resident microglia were the most likely cell types to contribute to MS susceptibility 1 . To examine if MS susceptibility genes were also expressed in OL lineage cells in EAE, we analyzed the expression of the mouse homologs for genes associated with the 200 non-MHC, 32 MHC loci, and 19 X-chromosomal loci in our single-cell transcriptomics dataset ( Fig. 3g , Supplementary  Fig. 6e and Supplementary Table 4 ). Interestingly, the MHC-II gene H2.Aa (human HLA-DQA1) was enriched not only in microglia, but also in EAE-derived OPCs and MOLs (Fig. 3g ). Strikingly, several OL lineage cells expressed non-MHC locus-associated susceptibility genes ( Fig. 3g and Supplementary Table 4 ). This was particularly strong for OPCs (importantly both from control and EAE mice) and MOL1/2-EAE populations (Fig. 3g ). OPCs expressed 61% of these genes, which was in the same range as microglia (67%). Moreover, while we found many genes are equally expressed in all the populations, there were also genes enriched in OL lineage cells (such as Bcas1 and Sox8), MOLs (Prr5l), OPCs (such as Kcnh8, Pkia, Pitpnm2) and microglia (such as Plek; Supplementary Table 4 ). Interestingly, a subset of genes starts to be expressed and is upregulated in response to the disease in MOL populations, in particular MOL1/2-EAE.
To investigate the mechanism triggering MHC-II expression in OL lineage cells and the functional implications in the development of the disease, we performed co-cultures of GFP + OPCs (from Sox10-Cre-GFP mice brains) and CD45 + immune cells isolated from the spinal cord of EAE mice (Fig. 4a ). After 72 h of co-culture, 4.4% (± 2.42 s.d.) of the total GFP + OPCs in culture were positive for MHC-II ( Fig. 4b ). We also performed co-cultures of OPCs with CD45 + immune cells from CFA mice (most likely comprising Letters NATurE MEDICINE of microglia/macrophages and a few invading leukocytes from the periphery) and did not find any GFP/MHC-II double-positive OPCs under these conditions ( Supplementary Fig. 8a ). This indicates that factors secreted by EAE-specific immune cells are inducing MHC-II expression in OPCs. Indeed, while MHC-II expression has been reported to be excluded from OLs in MS 16 , expression of these molecules in rat OPCs and OLs has been observed, on dexa-methasone and IFN-γ treatment 20 . As CD4 lymphocytes such as Th1 and memory T cells are interferon-producing cells, we hypothesized that the observed effect in the co-cultures was mediated by lymphocyte-derived IFN-γ . As such, we treated OPCs with IFN-γ (100 ng ml −1 ), dexamethasone (1 μ M) and the combination of both for 3 days (Fig. 4c ). We observed the induction of expression of MHC-II molecules, in OPCs and OLs, only in IFN-γ -treated cells, Non-MHC locus associated susceptibility genes 
Fig. 3 | Expression of MHC class ii and MS susceptibility genes in the OL lineage cells in response to
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alone or in combination with dexamethasone, both at the RNA level (RNAscope ISH) and protein level (shown by immunocytochemistry; Fig. 4d and Supplementary Fig. 8b ,c). We did not find any cells positive for Aif1 RNA molecules in our model-based analysis of (MACS) OPC primary cultures, nor IBA-1-positive cells, indicating that microglia were absent and excluding the possibility that MHC-II RNA and protein were derived from microglia processes. qPCR analysis further confirmed these results. While genes such as Plin4 were not affected by IFN-γ treatment but only by dexamethasone, we observed a dramatic induction of interferon-responsive genes (Ifit2, Ifih1), MHC-II genes (Cd74) and MHC-II and -I transactivators (Ciita, Nlrc5) ( Fig. 4e ). Thus, our results indicate that MHC-II gene induction in EAE OL lineage cells is possibly mediated by IFN-γ .
To uncover the role of immunocompetent OPCs in the disease, we first investigated if OPCs were capable of phagocytosis, by adding 1 μ m diameter fluorescent microspheres to OPC cultures for 24 h. OPCs could indeed take up several microspheres, with at least 48% of them exhibiting this capability ( Fig. 4f ). Moreover, treatment with the phagocytosis inhibitor cytochalasin D at two different concentrations for 24 h lead to a remarkable reduction in microsphere uptake ( Fig. 4f,g) . IFN-γ treatment did not alter OPC phagocytic capacity ( Fig. 4g ). To further investigate whether OPCs can phagocytose myelin, we incubated OPCs for 6 h with pHrodolabeled myelin (a pH-sensitive fluorogenic dye that fluoresces red in phagosomes 21 ) and found that OPCs were able to take up myelin as observed by the red fluorescence staining of live OPCs (Fig. 4f ). Altogether, these data demonstrate that OPCs exhibit phagocytic activity and strongly suggest that OPCs are capable of taking up myelin debris in a disease context.
Next, we addressed the impact of MHC-II-expressing OPCs on the survival, proliferation and cytokine production of CD4 + T cells derived from 2D2 mice, where T cells express the T cell receptor for the myelin oligodendrocyte glycoprotein (MOG 35-55) peptide 22 . OPCs (controls or pretreated with IFN-γ and/or MOG 35-55 peptide) were co-cultured for 72 h with either naïve, memory or effector T cells (naïve cells that had been pre-activated in vitro in the presence of IL-12, acquiring a Th1 phenotype). T cells were subsequently assessed by flow cytometry for survival (cell dead exclusion), proliferation (Ki67 + ), as well as for expression of IFN-γ and tumor necrosis factor (TNF) ( Fig. 4h and Supplementary  Fig. 8d ). Co-culturing with non-stimulated OPCs lead to an increase in numbers of surviving naïve, activated and memory T cells. Survival was further enhanced in memory T cells when OPCs were pretreated in IFN-γ and MOG peptide, suggesting an MHC-II-mediated effect ( Fig. 4i, Supplementary Figs. 8e and 9 ). Regarding proliferation, naïve CD4 + T cells seemed unaffected by OPC co-culture ( Fig. 4j and Supplementary Figs. 8e and 9 ), as expected, since these cells have a high threshold of activation provided in secondary lymphoid tissue. In contrast, we found a higher number of Ki67 + memory CD4 + T cells when co-cultured with OPCs in the presence of MOG peptide. Similar effects were observed for Th1 CD4 + T cells, which proliferated more in the presence of OPCs and MOG peptide. These results also suggest that the proliferation effect is via OPC-MOG peptide presentation to memory and Th1 T cells. Of note was that the presence of MOG peptide, not necessarily together with IFN-γ , was enough to induce proliferation. This indicates that production of IFN-γ by memory and Th1 cells may provide a positive regulatory feedback loop. We thus investigated if the increase in survival/proliferation was accompanied by cytokine production. Indeed, memory CD4 + T cells displayed more cells producing both TNF and IFNγ when co-cultured with OPCs in the presence of MOG peptide ( Supplementary Fig. 8d ). In contrast, the presence of OPCs per se triggered an increase in the number of Th1 CD4 + T cells producing IFN-γ and TNF ( Supplementary Fig. 8d ).
OLs are widely seen as a passive target of a dysregulated immune system, but there is a growing body of evidence of immunomodulatory factors expressed in OLs such as cytokines/chemokines and their receptors [23] [24] [25] [26] [27] . Our results indicate that both OPCs and MOLs undergo a transcriptional overhaul during chronic inflammatory demyelination. The selective expression of immunoprotective, innate and adaptive immunity genes in OPCs and OLs in EAE suggests potential mechanisms of protection and an immune function in the context of disease. Since several of these genes are susceptibility genes for MS, the OL lineage might have a more central role in the origin and progression of MS than previously thought.
OL cell death has been recently shown to lead to an adaptive autoimmune response 28 , which could imply an initial dysregulation in cells of the OL lineage as a triggering event in MS and support the 'inside-out' hypothesis for the etiology of the disease 28 . Whether the newly identified OL lineage cell states play a role in the etiology of MS, by acting as antigen-presenting cells and triggering immunologic attack or reinforcing the disease-initiating event from the periphery, or both, will require further investigation. In either case, our results indicate that OL lineage cells may not simply be passive targets of the immune system in MS, but rather central players that can be targeted in therapeutic approaches for MS.
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Methods
Information regarding methods used in this paper can be found below and also in the Life Sciences Reporting Summary.
Animals.
Mouse lines used in this study included C57BL/6NJ wild type (WT) mice, Pdgfra-Cre-LoxP-GFP 7 , Pdgfra-H2B-GFP knockin mice 6 , Sox10-Cre-LoxP-GFP 29 and C57Bl/6 2D2 transgenic mice 22 . Pdgfra-Cre-LoxP-GFP mice are a strain of mice obtained originally by crossing mice with Cre recombinase under the control of a Pdgfra genomic DNA fragment (with a C57BL/6NJ genetic background; The Jackson Laboratories) with reporter mice RCE:loxP-GFP (with CD1 background; G. Fishell, NYU Neuroscience Institute) to label the complete OL lineage. Sox10-Cre-LoxP-GFP mice are a strain of mice obtained originally by crossing mice with Cre recombinase under the control of the Sox10 promoter (The Jackson Laboratories; with a C57BL/6 genetic background) with reporter mice RCE:loxP-GFP (with CD1 background) to label the complete OL lineage. Pdgfra-H2B-GFP, with a C57BL/6NJ background, presents an H2B-eGFP fusion gene expressed under the promoter of the OPC marker, Pdgfra. Mice homozygous for the knockin targeted mutation have an embryonic lethal phenotype, with half of the embryos failing to survive past embryonic day 12.5 and the remainder failing to survive beyond embryonic day 15.5 (https://www.jax.org/strain/007669). Only heterozygote mice were used, in which Pdgfra is expressed mainly in OPCs but also to some extent in the early stages of OL differentiation, due to GFP half-life. Animals were used in adult stage, between 10 and 13 weeks old and both sexes were included. The following light/dark cycle was used: dawn 6:00-7:00; daylight 07:00-18:00; dusk 18:00-19:00; night 19:00-06:00. A maximum of 5 adult mice per individually ventilated cage of type II (Allentown). Breedings were done with 1 male and up to 2 females. All experimental procedures performed followed the guidelines and recommendations of local animal protection legislation and were approved by the local committee for ethical experiments on laboratory animals in Sweden (Stockholms Norra Djurförsöksetiska nämnd).
Experimental autoimmune encephalomyelitis.
For the induction of chronic EAE, animals were injected subcutaneously with an emulsion of MOG 35-55 in CFA (EK-2110 kit, Hooke Laboratories) followed by the administration of pertussis toxin in PBS (0.2 μ g per animal), for two consecutive days (all according to manufacturer's instructions). Spinal cords and cerebellum were collected at the peak/chronic stage of the disease with clinical score = 3 representing limp tail and complete paralysis of hind legs. Animals that did not reach this clinical score were not analyzed in this study. Additional animals were injected subcutaneously with a CFA emulsion (CK-2110 kit, Hooke Laboratories) and analyzed as controls.
Tissue dissociation for single-cell RNA-seq, FACS analysis and sequencing data processing. Cells were isolated from the spinal cord of P90 Pdgfra-H2B-GFP and Pdgfra-Cre-LoxP-GFP mice. Tissue was then dissociated into a singlecell suspension, as previously described 4 , with some modifications. Mice were perfused with oxygenated cutting solution (87 mM, NaCl, 2.5 mM KCl, 1.25 mM NaH 2 PO 4 , 26 mM NaHCO 3 , 75 mM sucrose, 20 mM glucose, 1 mM CaCl 2 and 2 mM MgSO 4 ) and the brain was quickly dissected and dissociated using the Adult Brain Dissociation Kit from Miltenyi (130-107-677) following the manufacturer's instructions (red blood cells removal step was not included). After debris removal, the cell suspension was filtered with a 30-μ m filter (Partec) and processed by FACS. Spinal cord single GFP + cells were selected in a BD Influx sorter and collected into a 384-well plate for Smart-seq2, according to procedures described in ref. 5 . Smart-seq2 raw data were processed according to procedures described in ref. 5 . Smart-seq2 paired-end reads were trimmed with cutadapt 1.8.0 30 and aligned with STAR 2.5.1b 31 to mm10 genome assembly. Only uniquely mapped reads were used for downstream analyses.
Primary OPC cell culture. Mice brains from P7 pups were removed and dissociated in single-cell suspensions using the Neural Tissue Dissociation Kit (P; Miltenyi Biotec, 130-092-628) according to the manufacturer's protocol. OPCs were obtained with MACS with CD140a microbeads following the manufacturer's protocol (CD140a Microbead kit, Miltenyi Biotec, 130-101-547). Alternatively to MACS, GFP + OPCs derived from Sox10-GFP mice were collected with FACS following brain dissociation. Cells were seeded in poly-llysine (O/N; Sigma P4707) plus fibronectin (1 h; Sigma F1141)-coated dishes and grown on proliferation media comprising DMEM/Gmax (ThermoFisher Scientific, 10565018), N2 media (ThermoFisher Scientific, 17502048), penicillinstreptomycin (ThermoFisher Scientific, 15140122), NeuroBrew (Miltenyi 130-093-566), bFGF 20 ng ml −1 (Peprotech, 100-18B) and PDGF-AA 10 ng ml −1 (Peprotech, 100-13A). For OPC differentiation, cells were left for 2 days in medium without bFGF and PDGF-AA. Cells were treated either with dexamethasone (1 μ M), IFN-γ (100 ng ml −1 ; R&D, 485-MI-100) or the combination of the two for 72 h. For the phagocytosis experiments, 1 μ l per ml of media of pHrodo-labeled myelin and 0.5 μ l per ml of media of Fluoresbrite Polychromatic Red Microspheres 1 μ m (Polysciences, Inc, 18660-5) were added to OPCs for 6 h and 24 h, respectively. Hoechst (ThermoFisher Scientific, 62249) was added at a dilution 1:1,000 to OPCs incubated with pHrodo-labeled myelin for live-cell fluorescent staining of the DNA and nuclei. Phagocytosis inhibition experiments were performed by adding two different concentrations of cytochalasin D (Sigma, C8273) (20 μ M and 50 μ M) in the presence or absence of IFN-γ (100 ng ml −1 ) for 24 h. Cells were thoroughly washed before fixation.
For the pHrodo-labeled myelin preparation myelin sheaths were obtained by dissection and mechanical homogenization of PBS-perfused mouse brains. Pure myelin was then isolated by several steps of density separation by ultracentrifugation in sucrose solutions 32, 33 . After several cleaning steps we incubated the purified myelin with pHrodo red (ThermoFisher, P36600) for 30 min following the manual instructions, followed by extensive washing in PBS/Hepes. OPC/CD45+EAE co-culture experiments. CFA and EAE mice were perfused in PBS and the spinal cords were collected. Immune cells (lymphocytes, monocytes and macrophages) were then isolated using the Adult Brain Dissociation Kit (Miltenyi Biotec, 130-107-677) according to the manufacturer's protocol and collected with MACS with CD45 + microbeads (CD45 Microbead kit, Miltenyi Biotec 130-052-301) according to the manufacturer's protocol. CD45 + cells (150,000-200,000) were added on top of cultured OPCs (300,000 cells) and incubated for 72 h.
OPC/T cell co-culture experiments.
Naïve and memory T cells were isolated from C57Bl/6 2D2 transgenic mice that express a T cell antigen receptor (TCR)-specific for the MOG 35-55 peptide 22 . Splenocytes were isolated by tissue disruption through a 100-μ m mesh and erythrocytes were lysed with ACK buffer (Invitrogen). Splenocytes were depleted from all non-T cells using a naïve CD4 + T cell Isolation Kit (Miltenyi, 130-104-453), and the flow through was further sorted into CD44 low (naïve) and CD44 high (memory) cells using anti-CD44 beads from the same kit. Cells were frozen in FCS containing 10% DMSO for subsequent experiments. Activated T cells were generated from naïve cells stimulated in vitro with platebound anti-CD3 (BD; 555273; 2 μ g ml −1 ) and soluble anti-CD28 (BD; 553294; 1 μ g ml −1 ) in the presence of 10 ng ml −1 IL-12 (R&D Systems, 419-ML) for 3 days, followed by 3 days expansion in 10 ng ml −1 IL-2 (R&D Systems, 402-ML) and cytokine starvation for 24 h prior to co-culture (with the exception of one n which was not deprived from cytokines).
OPCs (6 n's obtained with MACS and one n with FACS of GFP + cells from Sox10-GFP mice) were seeded at a density of 20,000 cells per well in a 96-well plate and pretreated with IFN-γ (100 ng ml −1 ) and/or MOG 35-55 peptide (Anaspec, AS-60130-5) at 40 μ g ml −1 for 72 h. Cells were washed twice in PBS. Naïve, memory and activated T cells were both seeded alone (with or without MOG 35-55 peptide at 40 μ g ml −1 ) and on top of control or stimulated OPCs at 2 × 10 5 cells/well in 96-well plates with MOG 35-55 peptide at 40 μ g ml −1 and incubated at 37 °C. Media used for T cells, as well as for T cell-OPC co-culture, was RPMI (Sigma, R8758), 10% FBS (v/v; Sigma F7524), penicillin-streptomycin (Sigma, P4458, 100 U ml −1 ). After 72 h, cells were stimulated for 5 h at 37 °C in media containing 50 ng ml −1 PMA (Sigma, P1585), 1 μ g ml −1 Ionomycin (Sigma, I0634) and 1 μ g ml −1 GolgiPlug (BD, 555029), to boost cytokine secretion, followed by staining for CD4 PE-Dazzle (BioLegend, 100566), Ki67 V450 (BD, 561281), anti-TCR Vbeta11 BV510 (BD, 743677), TNF PE-Cy7 (eBioscience, 25-7423-82), IFN-γ APC (BD, 554413) as well as dead cell exclusion dye near-IR (Invitrogen, L10119). Surface staining at 4 °C for 30 min was followed by fixation and permeabilization using an intracellular staining kit (eBioscience, 88-8824-00), followed by intracellular staining. For the relative assessment of cell survival and proliferation, samples were resuspended in equal volume and acquired by fixed time with a Gallios Flow Cytometer (Beckman Coulter) and analyzed using Kaluza Flow Cytometry Analysis Software (Beckman Coulter). Numbers of cells in the live gate as well as in the Ki67-positive gate reflect survival and proliferation since the same cell numbers were seeded on to different wells. All conditions were run in three biological replicates for each of the seven experiments. Averages of the assessed values for the different conditions were divided by the values of the control (T cells only) for fold differences.
RNA extraction, cDNA synthesis and quantitative real-time PCR (qRT-PCR).
Spinal cord and cerebellum were collected from WT control and EAE mice. OPCs and OLs from in vitro cultures were collected in 700 μ l Qiazol. RNA was extracted with the miRNeasy microkit (Qiagen, 217084) according to manufacturer's protocols. Contaminating DNA was degraded by treatment of the samples with RNase-free DNase (Qiagen, 79254) in column. RNA from each sample (0.35-1 µ g) was reverse transcribed for 1 h with the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, 4368813) including RNase inhibitor (Applied Biosystems, N8080119). A reverse transcriptase negative (RT− ) control was included for each sample. Both the cDNA and the RT were diluted 1:5 in RNase/DNAse-free water for qRT-PCR.
qRT-PCR reactions were run on a StepOnePlus™ System (Applied Biosystems) in duplicate and with RT− reactions to control for genomic DNA. Fast SYBR® Green Master Mix (Applied Biosystems, 4385616) was used according to the manufacturer's instructions, each PCR reaction had a final volume of 10 μ l and 1-2.5 μ l of diluted cDNA or RT− . The running conditions were 20 s at 95 °C, followed by 40 cycles of 3 s at 95 °C and 30 s at 60 °C, then 15 s at 95 °C, 1 min at 60 °C and 15 s at 95 °C. A melting curve was obtained for each PCR product after each run, to control for primer dimers and gene-specific peaks. Tbp and Gapdh were run as housekeeping genes.
Tissue processing for immunofluorescence and RNAscope ISH. For IHC and RNAscope ISH mice were perfused with PBS followed by 4% PFA. Spinal cords from EAE and control mice were dissected and post-fixed with 4% PFA for 1 h, at 4 °C. The tissues were embedded into OCT (Tissue-Tek), frozen in dry ice and sectioned coronally (20 μ m thickness). Sections were stored at − 80 °C.
For immunocytochemistry and RNAscope ISH in cultured cells, cells were fixed in 4% formaldehyde for 10 min and washed in PBS. Human brain 4 μ m paraffin sections, from regions with high microglia activity (thus active lesions) were dewaxed in a descending ethanol-row. After antigen retrieval and endogenous peroxidase quenching, they were incubated overnight at 4 °C with the following primary antibodies: OLIG1 (Abcam, 68105, 1:100), OLIG2 (Atlas, HPA003254, 1:200) and MHC-II (Dako, M0775 1:100) diluted in TBS/0.3% Triton/20% normal horse serum. After washing with TBS/0.001% Triton, they were incubated for 1 h at room temperature with goat F(ab) anti-rabbit IgG H&L (HRP) and goat F(ab) anti-mouse IgG H&L (HRP; ab7171 and ab6823 Abcam, 1:500). After washing in TBS/0.001% Triton, the fluorescence was visualized with tyramide kits from Perkin Elmer (NEL745B001KT and NEL744B001KT). The human tissue used in this study comprised one female and one male, aged 38 and 50 years respectively, both with secondary progressive MS. No patient had specific disease treatment. Postmortem MS tissue was provided via a UK prospective donor scheme with full ethical approval from the UK Multiple Sclerosis Tissue Bank (MREC/02/02/39).
Immunohistochemistry and immunocytochemistry (mouse and human samples). For immunocytochemistry, cells were incubated overnight at 4 °C with
RNAscope ISH. RNAscope ISH was performed on cultured cells and spinal cord sections from controls and EAE mice with probes for mouse Cd74, H2-Eb1, Aif1, Sox10, Klk6, Hopx, Ptpzr1, Serpina3n, B2m, Psmb9 and Klk8 all purchased from ACD. RNAscope ISH protocol for sections was performed following manufacturer's instructions with minor modifications (ACD, RNAscope® Multiplex Fluorescent Detection Reagents v2, 323110). Briefly, sections were placed on a hot plate (100 °C) with 1x target retrieval (Pretreatment Reagents, 322381 and 322000) for 5 min followed by 2 steps of washes of 2 min and 1 wash with 100% ethanol for 2 min. Protease IV was applied on top of the sections and incubated for 20 min at room temperature followed by 2 washes of 2 min each. Probes were diluted 1:50 in the C1 probe, hybridized for 2 h at 40 °C and washed twice in wash buffer (RNAscope® Wash Buffer Reagents, 310091). Amplification steps were performed by incubating with v2Amp1 (30 min), v2Amp2 (30 min) and v2Amp3 (15 min) at 40 °C with washes of 2 × 2 min in between steps (RNAscope® Multiplex Fluorescent Detection Reagents v2, 323110). Sections were incubated with v2-HRP-C1 for 15 min at 40 °C and washed twice in wash buffer for 2 min. TSA-conjugated fluorophores were diluted 1:1,500 in TSA buffer (RNAscope® Multiplex TSA Buffer, 322809) and incubated for 30 min at 40 °C followed by 2 washes of 2 min and HRP blocker incubation for 30 min at 40 °C. The last steps were performed subsequently for v2-HRP-C2 and v2-HRP-C3. To combine the RNAscope ISH with immunofluorescence for GFP, sections were further blocked in block with 5% normal donkey serum in 0.3% PBS-Tx100, 1 h, room temperature and incubated with chicken anti-GFP (abcam, ab13970 1:200) overnight at 4 °C. Sections were further incubated with goat anti-chicken (Alexa Fluor 488 1:500) for 2 h at room temperature and with DAPI (1:5,000) for 2 min.
Confocal microscopy and cell counting. Images from sections of both immunofluorescence and RNAscope ISH were acquired for the spinal cord using a Zeiss LSM700 Confocal, and processed in Fiji/ImageJ. Images from the human tissue were acquired using a Leica SP8 Confocal and processed in Fiji/ImageJ. Estimation of the percentage of the double MHC-II/SOX10-positive cells in the spinal cord of EAE mice was performed by counting the double-positive cells present in the lesion areas of the white matter divided by the total SOX10 + cells. The final percentage is represented as an average of 3 EAE mice. For the co-cultures the number of GFP/MHC-II double-positive cells were divided by the total number of GFP + cells. The final percentage is represented as an average of 3 independent experiments. For estimation of the percentage of OPCs that phagocytose microspheres, only OPCs with more than 10 microspheres surrounding the nucleus were considered as phagocytic OPCs. While this might have led to an underestimation of phagocytic OPCs, this way we have avoided counting OPCs with adherent and extracellular microspheres as phagocytic OPCs. Videos were obtained from z-stacks after processing with Imaris image analysis software.
Clustering analysis using GeneFocus pipeline. Quality control. Cells were clustered using a custom-made approach, which we developed and refer to as GeneFocus. We generated an iterative level 1 and level 2 clustering pipeline, taking advantage of diffusion mapping and spatial autocorrelation metrics to define relevant genes and cell clusters. First, cells were analyzed and quality control (QC) filtering was applied using the scater 1.6.0 in R. We applied cut-offs for the expression level 200,000 total FPKM and number of genes expressed 2,500, resulting in 2,304 and 1,777 cells pre-and post-QC, respectively. Median FPKM values were 395,721, and median gene counts were 3,694 genes.
Spatial gene filtering. Cells were normalized (see supplementary code in Github) and feature selection was performed using a support vector model from the e1071 R package (https://CRAN.R-project.org/package= e1071). The resulting expression matrix was then input into a custom pipeline performing iterative gene filtering in the following manner. We converted the expression matrix into a transition matrix using destiny 2.6.1 in R 35 with the input being the first 30 principal components of the expression matrix. Subsequently, a distance matrix was created from the transition matrix, after which the Morans I autocorrelation metric was computed for each gene using the spdep 0.6-15 R package 36 . Genes were filtered according to the mean Morans I computed for all the genes in the expression matrix, and this mean Morans I was set as a general threshold for subsequent gene filtering. After this initial filtering, a new diffusion map was computed and we iteratively repeated this process until all genes within the gene set remained above the determined threshold of spatial correlation set during the first round of gene filtering. A similar approach was performed using the transition matrix as a distance metric. A cut-off value was calculated using a support vector model that predicts a mean distance as a function of the population size in which the gene is expressed and the mean distance observed. We iterated the distance matrix until we obtained a gene set equal or smaller than the covered gene set obtained from the Morans I metric. A joint diffusion map was then created. Level 1 clustering. Level 1 clustering was established by estimating the ideal number of clusters by silhouette width using the principal components of the transition matrix, from which the number was estimated on the basis of an elbow plot. We estimated clusters using the factoextra 1.0.5 package (https://CRAN.R-project. org/package= factoextra) and hierarchical clustering using Ward's metric. We determined 5 initial clusters representing OPCs and early OLs, MOLs, VLMCs and pericytes, and microglial cells.
Level 2 clustering.
To determine more specific clustering and relevant genes we performed the iterative gene filtering on each of the subclusters. The threshold for the Morans I metric was established to be the mean Morans I of the gene set resulting from the second gene filtering round. This resulted in a final gene set for each subcluster varying between 800 and 1,000 spatially correlated genes per level 1 subcluster. Clusters were estimated by silhouette width and the final clustering was evaluated using the resulting heat map of the filtered genes.
For validation of the GeneFocus pipeline, we extracted the expression information from GEO from ref. 37 and were able to identify the disease-associated microglia cluster previously described 37 (Supplementary Fig. 2 ). To achieve our final clustering result, we also removed cells that were in clusters with less than 3 cells, resulting in a total of 1,765 cells. These cells seemed to be doublets based on mixed expression profiles.
Gene modules. To generate the gene modules, we performed NNMF, where ranks were established using a measure of mutual information with the elbow method. We established that 30 ranks were optimal to decompose the dataset. To select only robust components from the decomposed matrix, we performed PCA on the components and established an optimal k number of clusters based on Ward's metric. All component values falling within a cluster were summed, after which the new concatenated components were filtered based on a threshold of a Pearson correlation coefficient of 0.5 with any gene in the dataset. This resulted in 15 components that revealed the major gene trends underlying the data.
Differential expression and pathway visualization. Differential expression analysis was performed using the MAST R package v1.4.1 38 . Pathway visualization was performed using the clusterProfiler package v3.6.0 39 .
Comparison between OPCs in the current dataset and OPCs during development 3, 4 . The R package MetaNeighbor was used (https://github.com/ maggiecrow/MetaNeighbor).
Gene ontology and pathway analysis. Most significantly differentially expressed genes were selected for each of the GO analyses. For each cell type, unique top differentially upregulated genes in EAE and unique top differentially upregulated genes in controls were selected. For comparisons between cell types, uniquely differentially expressed genes for each cell category were selected. To make gene sets comparable, top 100 genes were selected. GO and pathway analysis were performed with Cytoscape 3.5.1 40 In accordance with the NNMF analysis, OPCs and OLs from EAE mice shared an enrichment for genes involved in the positive regulation of adaptive immune response, positive regulation of T cell-mediated cytotoxicity, response to interferon and antigen processing and presentation of endogenous peptides via MHC-I ( Supplementary Fig. 5a ). GO/Reactome analysis for the enriched genes in individual clusters indicated that OPC2-EAE was enriched in positive regulation of T cell-mediated cytotoxicity, antigen presentation, among other processes ( Supplementary Fig. 4c ). MOL1/2-EAE exhibited enrichment in similar processes, but also additional processes related to glycosylation ( Supplementary  Fig. 4c ), which has been implicated in the activation of adaptive immune activation 42 . In contrast to these populations, 'young' (Pdgfra-H2B-GFP) MOL5/6-EAE-a exhibited less pronounced upregulation in immune-related GO-terms ( Supplementary Fig. 4c ). Instead, this Plin4 + MOL cluster is enriched in genes related to lipid modification, gliogenesis and intrinsic apoptotic signaling pathway (with anti-apoptotic genes Bcl2l1, Cdkn1a and pro-apoptotic genes Bnip3, Ppp1r13b; Supplementary Table 1 ), among other categories ( Supplementary  Fig. 4c ).
Alternative splicing analysis. Alternatively spliced cassette exons were identified with BRIE 0.1.3 43 in the cell type clusters from Smart-seq2 data. Cassette exon annotations were extracted from Gencode.vM12 from protein-coding genes according to the parameters in ref. 43 . For each of the cells classified as MOL1/2, MOL5/6 and OPC, the fraction of exon inclusion was calculated (proportion of sliced isoform, PSI), with default parameters. Then, for each cell type, cell-to-cell pairwise comparisons were performed, comparing EAE-assigned with controlassigned cells. Significantly alternative spliced candidates were selected with the following parameters, Bayes factor > 10, delta PSI between the two cells > 0.2 and a minimum number of significant comparisons for each cell type (MOL1/2 ≥ 20, OPC ≥ 20 and MOL5/6 ≥ 100). To get more specific alternatively spliced exons, the candidate events were selected only when they were uniquely spliced in one direction for each cell type; for instance, events that are only skipped in EAE and events only included in EAE. Violin plots of selected events were plotted using all the PSI values for that specific alternative exon in EAE and in control, Wilcoxon rank-sum test with continuity correction was used for significance test. Visualization of the alternative spliced events junction reads was done with the merged bam files and the sashimi plot option in the integrative genomics viewer 44 .
MS susceptibility genes.
Genes assigned to human MS susceptibility SNPs were transformed to Mus musculus annotation using BioMart 45 . Human chromosome X-associated SNPs from ref. 1 were assigned to hg19 GENCODEv19 gene annotations with Bedtools v2.25.0 46 , with parameters windowbed -60000. Recovered genes were transformed to Mus musculus gene symbols using BioMart.
Ethics approval and consent to participate. The collection of all animal samples was performed according to the guidelines and recommendations of local animal protection legislation and were approved by the local committee for ethical experiments on laboratory animals in Sweden (Stockholms Norra Djurförsöksetiska nämnd). Human postmortem MS tissue was provided via a UK prospective donor scheme with full ethical approval from the UK Multiple Sclerosis Tissue Bank (MREC/02/02/39). All participants gave prospective premortem written consent for their brains to be banked and used for research.
Code availability. Code used for single-cell RNA-seq analysis is available at https://github.com/Castelo-Branco-lab/GeneFocus.
Data availability
A web resource for browsing differential gene expression data for the singlecell data can be accessed at https://ki.se/en/mbb/oligointernode. Raw data are deposited in GEO, accession number GSE113973. A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Data Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: -Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability
No restrictions apply on data availability. All figures have associated raw data, these are: Fig 1-4 and Supplementary Fig 1-9 , accession codes are provided.
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Sample size
No sample size calculation was performed to pre-determine sample sizes. Rationale for sample size choice is provided for each of the experiments described below.
For single cell RNA-seq, sample size was n=4 mice per condition, control or EAE. These 8 mice were sufficient to obtain the number of cells necessary to perform a confident data analysis and comparisons between controls and EAE mice.
For Immunohistochemistry and RNAscope ISH performed in mouse tissue, the sample size was n=3 per condition, control or EAE (at the exception of RNAscope/IHC in Supplementary Fig. 6a, b,c) . This sample size was found sufficient for validations of findings from single-cell RNA-seq because it is to demonstrate mostly presence of absence in EAE and control, respectively, of a certain protein and RNA.
For Immunohistochemistry of human samples the sample size was 2. This sample size is sufficient to prove the occurrence of our candidate genes in oligodendrocyte lineage cells in Multiple Sclerosis patients.
For qPCR analysis in tissue collected from control and EAE mice, sample size was n=4 and n=5, respectively, this sample size is often reported in previous publications with qPCRs analysis.
For primary cultures experiments the sample size was as it follows: qPCR: n=3, this sample size was found sufficient to the study since the expected differences between controls and treatments were robust. Immunocytochemistry for IFN-G and Dexamethasone treatment: n=3 RNAscope ISH in OPCs and OLs: n=3 Immunocytochemistry for co-culture of OPCs and EAE-derived CD45+ cells: n=3 The 3 techniques above, qPCR, RNAscope ISH and ICC demonstrate mostly presence or absence of a given protein and RNA upon treatment.
As such, we found n=3 sufficient for each technique. Immunocytochemistry for fluorescent microspheres experiments: n=3 pHrodo-labeled myelin experiment: n=3 These phagocytosis experiments demonstrate the capacity for phagocytosis, as such, n=3 for each experiment was sufficient. Furthermore, we also use 2 different methods to prove the same result.
Co-culture studies of OPCs with CD4+ T cells: n=7. This sample size was sufficient to allow us to take conclusions on CD4+ T cell survival/ proliferation and cytokine production.
Data exclusions For single cell RNA-Seq data, we excluded data points through our quality control pipeline, as indicated in the methods section in the paper. In short, data was excluded based on thresholding of cells expressing less than 220 000 counts, less than 2 500 genes, a count to mitochondrial count ratio of more than 2, and a count to ERCC spike in ratio of more than 35. Additionally we also removed cells that were clustered in clusters with less than 3 cells, these cells seemed to be doublets based on mixed expression profiles. These cutoffs were chosen based on data distribution curves, and are custom for the data itself. As of yet, there are no standard cutoffs for any cell-types, nor possible due to differences in aim, scope, cell types, cell sizes and cell numbers. Our cutoffs were relatively strict to ensure good quality cells.
Replication
Verification of the experimental findings derived from single cell RNA-seq is performed through validation of RNA-seq data with protein, RNA ISH staining experiments and qPCRs. All replications were successful.
Randomization For single-cell RNA-seq, we distributed females and males with similar ages equally in Controls and EAE. We also used two different transgenic mice: -4 Pdgfra-HistoneH2B-GFP, distributed in 2 controls and 2 EAE -4 PdgfraCre-RCE, distributed in 2 controls and 2 EAE.
Blinding
All analysis/counting involving immunohistochemistry/immunocytochemistry and RNAscope ISH were performed blindly.
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primary cultures, the P7 pup litters were pooled and the genders were mixed. For the 2D2 T-cells used in co-culture experiments both genders were used with ages between 8-16 weeks old.
Wild animals
The study did not involve wild animals
Field-collected samples
The study did not involve samples collected from the field.
Human research participants
Policy information about studies involving human research participants
Population characteristics
The human tissue used in this study comprised one female and one male , with ages of 38 and 50 years old both with secondary progressive multiple Sclerosis. No patient had specific disease treatment.
Recruitment
All participants gave prospective pre-mortem written consent for their brains to be banked and used for research.
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Methodology
Sample preparation
Naïve and memory T cells were isolate from the spleens of C57Bl/6 2D2 transgenic mice. Splenocytes were isolated by tissue disruption through a 100um mesh and erythrocytes were lysed with ACK buffer. Splenocytes were depleted from non-T cells using a naive CD4+ T Cell Isolation Kit (130-104-453; Miltenyi), and the flow through was further sorted into CD44 low (naïve) and CD44 high (memory) cells using anti-CD44 beads from the same kit.
Instrument
Gallios (Beckman Coulter)
Software
Kaluza for Gallios for sample acquisition; Kaluza analysis software for data analysis Cell population abundance The naïve T cell fraction was 81% CD4+ and 19% CD8+ and contained no detectable CD44hi (memory cells); the memory fraction was 94% CD4+ with a minor fraction of CD8+ T cells, but still contained 50% naïve T cell. Since naïve T cells are unresponsive in our experimental set up, their presence does not affect the results presented. Purity was determined by staining flow through and column-bound fractions with antibodies against CD3, CD4, Vb11, CD62L and CD44.
Gating strategy
Cells were identified first on FSC/SSC plots; dead cells were subsequently gated away using a LIVE/DEAD Fixable Near-IR Dead Cell Stain (Invitrogen); live cells were plotted against CD4 and Vb11 for the determination of double positive cells; these were in turn analyzed for the expression of Ki67, IFNg or TNF.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
